Inflammation is responsible for systemic bone loss in patients with seropositive rheumatoid arthritis treated with rituximab
Mie Jin Lim, Kyong-Hee Jung, Seong-Ryul Kwon, Won Park
Korean J Intern Med. 2023;38(6):912-922. Published online 2023 Oct 23 DOI: https://doi.org/10.3904/kjim.2023.080
Citations to this article as recorded by 
Impact of biologic and targeted synthetic therapies on bone health in immune-mediated inflammatory diseases: a narrative review
Isabel de la Cámara-Fernández, Tatiana Cobo-Ibáñez, Olga María Reillo-Sánchez, Gabriela Nataly Cueva-Nájera, Ana Valeria Acosta-Alfaro, Santiago Muñoz-Fernández
Frontiers in Medicine.2026;[Epub] CrossRef
Evaluating disease activity scores and CBC-derived indices in relation to osteoporosis risk in rheumatoid arthritis: a cross-sectional analysis
Di Jin, Lina Zhang, Yuwei Wang, Yufeng Pan, Weiduo Nie, Sheng-Guang Li, Yuhua Yan, Ming Li
Frontiers in Immunology.2026;[Epub] CrossRef